$PCRX Pacira BioSciences, Inc. Insider Trading Week 24/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. in week 24/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Option Exercise | A | 44.20 | 8,144 | 359,965 | 8,144 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,357 | 0 | 3,845 | 2.5 K to 3.8 K (+54.54 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 11,000 | 0 | 24,773 | 13.8 K to 24.8 K (+79.87 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 44.20 | 9,000 | 397,800 | 9,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 4,864 | 364 to 4.9 K (+1,236.26 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 44.20 | 81,000 | 3,580,200 | 81,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 40,500 | 0 | 100,059 | 59.6 K to 100.1 K (+68.00 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | A | 44.20 | 17,500 | 773,500 | 17,500 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Grant | A | 0.00 | 8,750 | 0 | 13,593 | 4.8 K to 13.6 K (+180.67 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 44.20 | 6,000 | 265,200 | 6,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,000 | 0 | 10,063 | 7.1 K to 10.1 K (+42.47 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 44.20 | 17,500 | 773,500 | 17,500 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 44.20 | 15,000 | 663,000 | 15,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 7,500 | 0 | 17,313 | 9.8 K to 17.3 K (+76.43 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.20 | 22,000 | 972,400 | 22,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 44.10 | 10,000 | 441,000 | 10,000 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 11,000 | 0 | 20,982 | 10 K to 21 K (+110.20 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,357 | 0 | 7,490 | 6.1 K to 7.5 K (+22.13 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,357 | 0 | 23,537 | 22.2 K to 23.5 K (+6.12 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,357 | 0 | 5,145 | 3.8 K to 5.1 K (+35.82 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,357 | 0 | 5,795 | 4.4 K to 5.8 K (+30.58 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,357 | 0 | 4,562 | 3.2 K to 4.6 K (+42.34 %) |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 44.20 | 2,714 | 119,959 | 2,714 | |
| Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,357 | 0 | 4,845 | 3.5 K to 4.8 K (+38.90 %) |